Deerfield Mgmt Cuts Cabaletta Bio Stake to 1 Shared Vote

TL;DR

**Deerfield Mgmt just dumped almost all its CABA shares, watch out!**

AI Summary

Deerfield Mgmt, L.P., a Delaware-organized entity, has filed an amended SC 13G/A for Cabaletta Bio, Inc. (NASDAQ: CABA) as of December 31, 2023. This filing indicates that Deerfield Mgmt, L.P. now holds 0 shares with sole voting power and 1 share with shared voting power, a significant reduction from previous holdings. This matters to investors because a major institutional investor has drastically reduced its stake, potentially signaling a loss of confidence or a strategic portfolio reallocation, which could influence other investors' perceptions of Cabaletta Bio's future prospects.

Why It Matters

This filing shows a major institutional investor, Deerfield Mgmt, L.P., has significantly reduced its beneficial ownership in Cabaletta Bio, Inc., which could be interpreted as a bearish signal by the market.

Risk Assessment

Risk Level: medium — A substantial reduction in holdings by a major institutional investor like Deerfield Mgmt can indicate potential concerns about the company's future, increasing investment risk.

Analyst Insight

Investors should investigate the reasons behind Deerfield Mgmt's drastic reduction in Cabaletta Bio shares and consider if this signals underlying issues or a change in the company's prospects before making investment decisions.

Key Numbers

• 0 — Sole Voting Power Shares (Deerfield Mgmt, L.P.'s current sole voting power in Cabaletta Bio, Inc.)
• 1 — Shared Voting Power Shares (Deerfield Mgmt, L.P.'s current shared voting power in Cabaletta Bio, Inc.)

Key Players & Entities

• Deerfield Mgmt, L.P. (company) — reporting person and institutional investor
• Cabaletta Bio, Inc. (company) — the issuer whose securities are being reported
• James E. Flynn (person) — filed on behalf of Deerfield Management group
• December 31, 2023 (date) — date of event requiring the filing
• Delaware (company) — place of organization for Deerfield Mgmt, L.P.

Forward-Looking Statements

• Other institutional investors may re-evaluate their positions in Cabaletta Bio, Inc. following Deerfield Mgmt's significant reduction in holdings. (Cabaletta Bio, Inc.) — medium confidence, target: Q1 2024

FAQ

Filing Documents

• e619242_sc13ga-cb.htm (SC 13G/A) — 126KB
• 0001193805-24-000180.txt ( ) — 127KB

(a)

Item 1(a). Name of Issuer: Cabaletta Bio, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 2929 Arch Street, Suite 600 Philadelphia, PA 19104

(a)

Item 2(a). Name of Person Filing: James E. Flynn, Deerfield Mgmt, L.P., Deerfield Partners, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P. and Deerfield Private Design Fund IV, L.P.

(b)

Item 2(b). Address of Principal Business Office, or if None, Residence: James E. Flynn, Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Partners, L.P., Deerfield Management Company, and Deerfield Private Design Fund IV, L.P., 345 Park Avenue South, 12th Floor, New York, NY 10010

(c)

Item 2(c). Citizenship: Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., Deerfield Mgmt IV, L.P., and Deerfield Private Design Fund IV, L.P. - Delaware limited partnerships; James E. Flynn – United States citizen

(d)

Item 2(d). Title of Class of Securities: Common Stock

(e)

Item 2(e). CUSIP Number: 12674W109 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act. (b) Bank as defined in Section 3(a)(6) of the Exchange Act. (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) Investment company registered under Section 8 of the Investment Company Act. (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); CUSIP No. 12674W109 13G Page 7 of 11 (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _________________ Item 4. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned**: Deerfield Mgmt, L.P. - 1,543,477 shares Deerfield Management Company, L.P. - 2,007,729 shares Deerfield Mgmt IV, L.P. – 464,252 shares Deerfield Partners, L.P. - 1,543,477 shares Deerfield Private Design Fund IV, L.P. - 464,252 shares James E. Flynn – 2,007,729 shares (b) Percent of class**: Deerfield Mgmt, L.P. – 3.60% Deerfield Management Company, L.P. - 4.69% Deerfield Mgmt IV, L.P. – 1.08% Deerfield Partners, L.P. – 3.60% Deerfield Private Design Fund IV, L.P. – 1.08% James

View Full Filing

View this SC 13G/A filing on SEC EDGAR